PMID: 5891190Oct 8, 1965

Hemolysin of Mycoplasma pneumoniae: tentative identification as a peroxide

Science
N L SomersonR M Chanock

Abstract

Mycoplasma pneumoniae produces a soluble hemolysin active against guinea pig erythrocytes. This hemolysin appears to be a peroxide, since catalase or peroxidase inhibits its activity. The action of catalase and peroxidase is specific, since heating the enzymes abolishes their effect on the hemolysin. In addition, 3-amino- 1,2,4-triazole, a potent inhibitor of catalase, reverses the inhibitory effect of the enzyme. The hemolysin of M. laidlawii is also a peroxide. The hemolysins of M. pneumoniae and M. laidlawii seem unique for microbial organisms since the bacterial hemolysins which have been described have been protein or lipid in nature.

References

Jan 1, 1953·Antonie van Leeuwenhoek·A TASMAN, J VAN DER SLOT
Jan 1, 1963·Journal of General Microbiology·S RAZIN, A COHEN

Citations

Jul 1, 1985·Diagnostic Microbiology and Infectious Disease·A M CollierW A Clyde
Nov 25, 1965·The New England Journal of Medicine·R M Chanock
Oct 19, 2004·Clinical Microbiology Reviews·Ken B Waites, Deborah F Talkington
Oct 15, 2005·Clinical Microbiology Reviews·Ken B WaitesRobert L Schelonka
Oct 24, 2007·Infection and Immunity·Takashi ShimizuKoichi Kuwano
Dec 22, 2006·Journal of Molecular Microbiology and Biotechnology·Sven HalbedelJörg Stülke
May 29, 2010·American Journal of Respiratory and Critical Care Medicine·Chonnamet TechasaensiriR Doug Hardy
Mar 1, 1967·The Journal of Clinical Investigation·J T DodgeG B Phillips
May 3, 2012·TheScientificWorldJournal·Michael KubeErich Seemüller
Jul 28, 1967·Annals of the New York Academy of Sciences·W A Clyde, K S Kim
Jul 28, 1967·Annals of the New York Academy of Sciences·C B SmithR H Alford
Jul 28, 1967·Annals of the New York Academy of Sciences·M F Barile
Jul 28, 1967·Annals of the New York Academy of Sciences·J F Hers, N Masurel
Jul 28, 1967·Annals of the New York Academy of Sciences·G Cohen, N L Somerson
Jan 1, 1981·Scandinavian Journal of Infectious Diseases·F D Lindström, B Ståhl-Furenhed
Feb 1, 1972·The American Journal of Medicine·E Barrett-Connor
Sep 16, 1980·Biochemical and Biophysical Research Communications·R E Lynch, B C Cole
Apr 1, 1970·Journal of Comparative Pathology·D H Roberts, T W Little
Jan 1, 1984·Microbiology and Immunology·M YayoshiM Yoshioka
Apr 12, 2016·Frontiers in Microbiology·Takashi Shimizu
May 6, 2016·Frontiers in Microbiology·Gretchen L ParrottJiro Fujita
Aug 16, 2015·BMC Genomics·Li XiaoKevin Dybvig
Dec 12, 1970·Nature·J D Cherry, D Taylor-Robinson
Jul 29, 1967·Nature·D Taylor-Robinson, R J Manchee
Nov 26, 2008·Journal of Bacteriology·Claudine HamesJörg Stülke
Aug 26, 1967·Nature·M H Williams, D Taylor-Robinson
Oct 30, 1970·Annals of the New York Academy of Sciences·V L Sutter, S M Finegold
Nov 21, 2017·Cellular Microbiology·Oliver A PrinceDuncan C Krause
Sep 30, 2017·FEMS Microbiology Reviews·Cedric Blötz, Jörg Stülke
Aug 24, 1999·Infection and Immunity·M BendjennatE Bahraoui

Related Concepts

Catalase T
Erythrocytes
Cavia porcellus
Hemolysin
Mycoplasma putrefaciens
Peroxides
Respiratory Tract Structure
Pathogenicity
Culture Techniques

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.